🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 2 double-blind, randomized, placebo-controlled study to evaluate re...
Status
Recruiting
Location
University of California San Diego
Start Date
2025-12-29
Trial ID
NCT07335601
Treatments Being Tested
The purpose of this study is to determine whether MGL-3196 alters the pharm...
Status
Completed
Location
Celerion
Start Date
2015-09
Trial ID
NCT02542969
Treatments Being Tested
The purpose of this study is to determine whether the single and multiple-d...
Status
Completed
Location
Celerion
Start Date
2019-07-26
Trial ID
NCT04671069
Treatments Being Tested
The purpose of this study is to directly characterize the pharmacokinetic (...
Status
Completed
Location
Madrigal Research Center
Start Date
2024-03-06
Trial ID
NCT06397872
Treatments Being Tested
The purpose of this study is to directly characterize the pharmacokinetic (...
Status
Completed
Location
Madrigal Research Center
Start Date
2018-10-25
Trial ID
NCT04643795
Treatments Being Tested
The purpose of this study is to determine whether the single-dose pharmacok...
Status
Completed
Location
Celerion
Start Date
2018-11-09
Trial ID
NCT04671056
Treatments Being Tested
A double-blind placebo controlled randomized Phase 3 study to determine if ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-03-28
Trial ID
NCT03900429
Treatments Being Tested
The purpose of this study is to determine whether MGL-3196 alters the pharm...
Status
Completed
Location
Celerion
Start Date
2016-04
Trial ID
NCT02749578
Treatments Being Tested
This randomized control trial aims to evaluate the effectiveness of combini...
Status
Not Yet Recruiting
Location
CUNY Graduate School of Public Health and Health Policy
Start Date
2026-10-01
Trial ID
NCT07680478
Treatments Being Tested
This is an open-label, 2-cohort study to evaluate the mutual DDI potential ...
Status
Completed
Location
Celerion
Start Date
2025-09-30
Trial ID
NCT07216313
Treatments Being Tested